loading
Schlusskurs vom Vortag:
$1.37
Offen:
$1.41
24-Stunden-Volumen:
64,739
Relative Volume:
0.70
Marktkapitalisierung:
$2.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-5.00M
KGV:
-1.139
EPS:
-1.15
Netto-Cashflow:
$-3.85M
1W Leistung:
-17.09%
1M Leistung:
-40.46%
6M Leistung:
-61.92%
1J Leistung:
-85.43%
1-Tages-Spanne:
Value
$1.25
$1.41
1-Wochen-Bereich:
Value
$1.25
$1.6762
52-Wochen-Spanne:
Value
$1.25
$14.28

Protagenic Therapeutics Inc Stock (PTIX) Company Profile

Name
Firmenname
Protagenic Therapeutics Inc
Name
Telefon
(212) 994-8200
Name
Adresse
149 FIFTH AVENUE, NEW YORK
Name
Mitarbeiter
5
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
PTIX's Discussions on Twitter

Vergleichen Sie PTIX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PTIX
Protagenic Therapeutics Inc
1.3099 2.64M 0 -5.00M -3.85M -1.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
448.12 114.05B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
747.16 78.80B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
847.92 53.08B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
394.94 51.80B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
165.08 42.33B 447.02M -1.18B -906.14M -6.1812

Protagenic Therapeutics Inc Aktie (PTIX) Neueste Nachrichten

pulisher
07:56 AM

Gap Down: Can Protagenic Therapeutics Inc. stock maintain growth trajectoryQuarterly Trade Review & Growth-Oriented Investment Plans - Улправда

07:56 AM
pulisher
Dec 13, 2025

What analysts say about Protagenic Therapeutics Inc stockValue Stock Picks & Rapid Capital Gain - earlytimes.in

Dec 13, 2025
pulisher
Dec 11, 2025

Protagenic reports results from phase 1 multiple-dose study of PT00114 - MSN

Dec 11, 2025
pulisher
Dec 11, 2025

Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice - Bluffton Today

Dec 11, 2025
pulisher
Dec 10, 2025

Taking on analysts’ expectations and winning: Protagenic Therapeutics Inc (PTIX) - setenews.com

Dec 10, 2025
pulisher
Dec 09, 2025

Protagenic Therapeutics (PTIX) Shares Phase 1 Study Results for PT00114 - GuruFocus

Dec 09, 2025
pulisher
Dec 09, 2025

Protagenic reports positive safety results for stress disorder drug By Investing.com - Investing.com Canada

Dec 09, 2025
pulisher
Dec 09, 2025

Protagenic reports positive safety results for stress disorder drug - Investing.com

Dec 09, 2025
pulisher
Dec 09, 2025

Results from Phase 1 Multiple-Dose Study of PT00114 - ACCESS Newswire

Dec 09, 2025
pulisher
Dec 09, 2025

Protagenic Therapeutics (NASDAQ: PTIX) reports positive Phase 1 multiple-dose safety data for PT00114 - Stock Titan

Dec 09, 2025
pulisher
Dec 06, 2025

What Makes Kalyan Jewellers India Limited Stand Out Among CompetitorsSupport and Resistance Levels & Minimal Investment Portfolio - earlytimes.in

Dec 06, 2025
pulisher
Dec 05, 2025

Will Protagenic Therapeutics Inc. (MBP0) stock profit from automation waveWeekly Trade Recap & Pattern Based Trade Signal System - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Is Protagenic Therapeutics Inc. (MBP0) stock a buy before new product rollout2025 Support & Resistance & Daily Profit Focused Stock Screening - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Will Protagenic Therapeutics Inc. (MBP0) stock enhance shareholder valueJuly 2025 Fed Impact & Scalable Portfolio Growth Methods - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Can Protagenic Therapeutics Inc. (MBP0) stock expand revenue streamsJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

How dovish Fed policy supports Protagenic Therapeutics Inc. (MBP0) stockQuarterly Market Review & Free High Return Stock Watch Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Is Protagenic Therapeutics Inc. Equity Warrant stock positioned well for digital economy2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Is Protagenic Therapeutics Inc. stock gaining market shareJuly 2025 Weekly Recap & Community Supported Trade Ideas - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Can Protagenic Therapeutics Inc. (MBP0) stock attract ESG investmentsJuly 2025 Rallies & Technical Pattern Alert System - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

CapEx per share of Protagenic Therapeutics, Inc. – GETTEX:MBP0 - TradingView

Dec 03, 2025
pulisher
Dec 03, 2025

Will Protagenic Therapeutics Inc. Equity Warrant stock attract ESG investorsMarket Sentiment Review & Daily Momentum Trading Reports - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

How Protagenic Therapeutics Inc. (MBP0) stock behaves in tightening cycles2025 Winners & Losers & Low Risk Investment Opportunities - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Why Protagenic Therapeutics Inc. (MBP0) stock could be next leaderJuly 2025 Sentiment & Stepwise Trade Execution Plans - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Protagenic Therapeutics (PTIX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 02, 2025

How robust is Protagenic Therapeutics Inc. (MBP0) stock financial position - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Why Protagenic Therapeutics Inc. (MBP0) stock is a must watch tickerMarket Growth Review & Free Technical Pattern Based Buy Signals - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

ETF Watch: Can Protagenic Therapeutics Inc stock maintain growth trajectoryGlobal Markets & Entry Point Strategy Guides - BỘ NỘI VỤ

Dec 01, 2025
pulisher
Nov 29, 2025

US Stocks Recap: Can Protagenic Therapeutics Inc. stock maintain growth trajectoryGDP Growth & Proven Capital Preservation Tips - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 28, 2025

Protagenic Therapeutics Faces Nasdaq Delisting Due to Compliance Issues - marketscreener.com

Nov 28, 2025
pulisher
Nov 27, 2025

Can Protagenic Therapeutics Inc. stock maintain growth trajectoryEarnings Overview Report & Free Expert Approved Momentum Trade Ideas - moha.gov.vn

Nov 27, 2025
pulisher
Nov 27, 2025

Protagenic Therapeutics, Inc. (PTIX) Stock: Faces Nasdaq Delisting Risk Amid Equity and Filing Issues - parameter.io

Nov 27, 2025
pulisher
Nov 27, 2025

Can Protagenic Therapeutics Inc. stock attract ESG capital inflowsDollar Strength & Scalable Portfolio Growth Methods - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 27, 2025

Protagenic Therapeutics receives Nasdaq non-compliance letter - MSN

Nov 27, 2025
pulisher
Nov 27, 2025

Does Protagenic Therapeutics Inc (PTIX) offer a good opportunity for investors? - Setenews

Nov 27, 2025
pulisher
Nov 27, 2025

Protagenic Therapeutics (PTIX) Faces Nasdaq Delisting Over Compl - GuruFocus

Nov 27, 2025
pulisher
Nov 27, 2025

Protagenic Therapeutics (Nasdaq: PTIX) hit with Nasdaq notice for $2.5M deficit, late 10-Q - Stock Titan

Nov 27, 2025
pulisher
Nov 26, 2025

Protagenic Therapeutics Faces Nasdaq Delisting Notice - MSN

Nov 26, 2025
pulisher
Nov 26, 2025

Protagenic Therapeutics, Inc. (PTIX) -8.1% in After-hours: Stock Declines Despite Recent Milestones - Stocks Telegraph

Nov 26, 2025
pulisher
Nov 26, 2025

Protagenic Therapeutics, Inc.\new SEC 10-Q Report - TradingView

Nov 26, 2025
pulisher
Nov 26, 2025

Protagenic Therapeutics gets Nasdaq notice for equity and filing issues - Stock Titan

Nov 26, 2025
pulisher
Nov 26, 2025

Is Protagenic Therapeutics Inc. Equity Warrant stock supported by strong fundamentalsJuly 2025 PostEarnings & Growth Oriented Trade Recommendations - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 23, 2025

Protagenic Therapeutics Inc MBP0 Stock Analysis and ForecastEarnings Date Calendar & Affordable Stock Market Tips - earlytimes.in

Nov 23, 2025
pulisher
Nov 23, 2025

Atrinsic (NASDAQ:PTIX) Trading Up 2.5% – Time to Buy? - Defense World

Nov 23, 2025
pulisher
Nov 22, 2025

Protagenic Therapeutics Merges With Phytanix Bio In All-Stock Deal: Retail Turns Extremely Bullish - MSN

Nov 22, 2025
pulisher
Nov 21, 2025

Protagenic Therapeutics Inc. (PTIX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 21, 2025

Will Protagenic Therapeutics Inc. Equity Warrant stock benefit from upcoming earnings reportsTrade Entry Summary & Proven Capital Preservation Methods - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Protagenic Therapeutics Inc. Equity Warrant stock a buy before product launches2025 Macro Impact & Verified Momentum Watchlists - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

What analysts say about Protagenic Therapeutics Inc Equity Warrant stockCapital Gains Strategies & Minimal Capital Growth Plans - earlytimes.in

Nov 20, 2025

Finanzdaten der Protagenic Therapeutics Inc-Aktie (PTIX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$38.44
price up icon 0.38%
$97.55
price down icon 0.15%
$31.56
price down icon 0.57%
$91.78
price down icon 0.00%
biotechnology ONC
$308.56
price up icon 0.67%
$165.08
price down icon 16.91%
Kapitalisierung:     |  Volumen (24h):